Multistability in a Model for CTL Response to HTLV-I Infection and Its Implications to HAM/TSP Development and Prevention

Human T-cell leukaemia/lymphoma virus type I (HTLV-I) is a retrovirus that has been identified as the causative agent of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and other illnesses. HTLV-I infects primarily CD4+ T cells and the transmission occurs through direct cell-to-cell contact. HAM/TSP patients harbor higher proviral loads in peripheral blood lymphocytes than asymptomatic carriers. Also, HAM/TSP patients exhibit a remarkably high number of circulating HTLV-I-specific CD8+ cytotoxic T lymphocytes (CTLs) in the peripheral blood. While CTLs have a protective role by killing the infected cells and lowering the proviral load, a high level of CTLs and their cytotoxicity are believed to be a main cause of the development of HAM/TSP. A mathematical model for HTLV-I infection of CD4+ T cells that incorporates the CD8+ cytotoxic T-cell (CTL) response is investigated. Our mathematical analysis reveals that the system can stabilize at a carrier steady-state with persistent viral infection but no CTL response, or at a HAM/TSP steady-state at which both the viral infection and CTL response are persistent. We also establish two threshold parameters R0 and R1, the basic reproduction numbers for viral persistence and for CTL response, respectively. We show that the parameter R1 can be used to distinguish asymptomatic carriers from HAM/TSP patients, and as an important control parameter for preventing the development of HAM/TSP.

[1]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[2]  R. Wilks,et al.  Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. , 1991, Blood.

[3]  M. Nowak,et al.  Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.

[4]  I. Elovaara,et al.  High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease , 1993, The Journal of experimental medicine.

[5]  Mitsuhiro Osame,et al.  Spread of HTLV-I Between Lymphocytes by Virus-Induced Polarization of the Cytoskeleton , 2003, Science.

[6]  M. Nowak,et al.  Virus dynamics: Mathematical principles of immunology and virology , 2001 .

[7]  S. Jacobson,et al.  Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). , 2002, Blood.

[8]  A. Perelson,et al.  A model of HIV-1 pathogenesis that includes an intracellular delay. , 2000, Mathematical biosciences.

[9]  Michael Y. Li,et al.  Backward bifurcation in a model for HTLV-I infection of CD4+ T cells , 2005, Bulletin of mathematical biology.

[10]  M. Baseler,et al.  Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. , 1993, Journal of immunology.

[11]  W. Blattner,et al.  Retroviruses—Human T-Cell Lymphotropic Virus , 1997 .

[12]  L. Mansky In Vivo Analysis of Human T-Cell Leukemia Virus Type 1 Reverse Transcription Accuracy , 2000, Journal of Virology.

[13]  Y. Itoyama,et al.  A Quantitative Polymerase Chain Reaction Study , 2004 .

[14]  C. Bangham,et al.  Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. , 1992, Virology.

[15]  J. P. Lasalle The stability of dynamical systems , 1976 .

[16]  A. Perelson Modeling the interaction of the immune system with HIV , 1989 .

[17]  K. Okochi,et al.  A Retrospective Study on Transmission of Adult T Cell Leukemia Virus by Blood Transfusion: Seroconversion in Recipients , 1984, Vox sanguinis.

[18]  R. Ferguson,et al.  LYMPHOID CELLS IN JEJUNAL MUCOSA , 1975, The Lancet.

[19]  C. Castillo-Chavez Mathematical and Statistical Approaches to Aids Epidemiology , 1989 .

[20]  Alan S. Perelson,et al.  Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..

[21]  Masahiro Nagai,et al.  Increased HTLV‐I proviral load and preferential expansion of HTLV‐I tax‐specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP , 2001, Annals of neurology.

[22]  E. Jaffee,et al.  Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Jacobson Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. , 2002, The Journal of infectious diseases.

[24]  M. Nowak,et al.  The dynamics of HTLV-I and the CTL response. , 1999, Immunology today.

[25]  Mitsuhiro Osame,et al.  Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy , 1993, Journal of Neuroimmunology.

[26]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[27]  M. Matsuoka Chapter 29 – Human T-Cell Leukemia Virus Type I , 2006 .

[28]  F. Miedema,et al.  T cell dynamics in HIV-1 infection. , 1999, Advances in immunology.

[29]  E. Majorovits,et al.  The immune control of HTLV-1 infection: selection forces and dynamics. , 2009, Frontiers in bioscience.

[30]  B. de Thoisy,et al.  Two-Step Nature of Human T-Cell Leukemia Virus Type 1 Replication in Experimentally Infected Squirrel Monkeys (Saimiri sciureus) , 2001, Journal of Virology.

[31]  C. Bangham,et al.  Cell-mediated immune response to human T-lymphotropic virus type I. , 2005, Viral immunology.

[32]  B. Asquith,et al.  Quantifying HTLV‐I dynamics , 2007, Immunology and cell biology.

[33]  C. Bangham,et al.  The immune response to HTLV-I. , 2000, Current opinion in immunology.

[34]  Steven A. Orszag,et al.  CBMS-NSF REGIONAL CONFERENCE SERIES IN APPLIED MATHEMATICS , 1978 .

[35]  Jing Zhang,et al.  AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro. , 1997, The Journal of general virology.

[36]  R. Janssen,et al.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. , 1990, Journal of acquired immune deficiency syndromes.

[37]  P Rudge,et al.  In vivo cellular tropism of human T-cell leukemia virus type 1 , 1990, Journal of virology.